Lung Health
As respiratory and pulmonary medicine continues to advance, staying ahead of the curve has never been more critical. In 2025, important therapeutic approvals, major guideline updates, and progress in personalized medicine, artificial intelligence, and diagnostics reshaped how respiratory and pulmonary diseases are understood and managed. As we welcome the new year, we asked our touchRESPIRATORY 2025 Future Leaders to share the developments they believe will shape the future of the field. Here, they highlight three emerging areas poised to influence clinical practice—not only in the year ahead, but for years to come.
As 2025 draws to a close, we’re celebrating another remarkable year of growth, collaboration and innovation at touchRESPIRATORY. From thought-provoking expert interviews and peer-reviewed research to dynamic conference coverage and an expanding portfolio of medical education, this year has been defined by meaningful conversations and impactful learning. We’ve had the privilege of engaging with leading clinicians, researchers and partner societies across the globe - bringing together diverse voices to support the respiratory community with timely, accessible and authoritative content. As we reflect on the past 12 months, we’re proud to highlight the moments, milestones and stories that shaped our year.
The CHEST 2025 annual meeting brought together pulmonary, critical care, and sleep medicine experts to share emerging science, clinical insights, and forward-looking innovations shaping respiratory care. Through focused conversations with leaders across the field, these interviews highlight practical, practice-ready insights that clinicians can bring directly to patient care.
Smoking cessation is essential in chronic respiratory disease, yet clinicians must navigate evolving evidence, diverse patient needs, and persistent inequities in care. In this Q&A, Dr Humayun Anjum discusses current data on e-cigarettes, practical strategies for individualising cessation support, and approaches to embedding health equity into clinical practice. He highlights policy, community, and clinical interventions that expand access to evidence-based resources, particularly for underserved populations.
In this episode, Nicky speaks with Prof. Georgina Ellison-Hughes from King’s College London about the groundbreaking field of senolytics and their potential to advance the treatment of age-related diseases. From understanding the science behind cellular senescence to how senolytic drugs work and what early clinical trials reveal, this episode explores an exciting frontier in longevity medicine.
The ERS Congress 2025 in Amsterdam showcased the latest advances in respiratory medicine, featuring cutting-edge research, interactive workshops, and sessions across 14 specialist assemblies. Highlights included live endoscopy demonstrations, updates on lung cancer projects, and innovative programmes for early career professionals. This year’s congress underscored global collaboration and innovation in respiratory health. touchRESPIRATORY were delighted to speak with leading experts at ERS 2025, sharing insights on some of the congress’s key presentations and breakthroughs in respiratory medicine.
The American Lung Association (ALA) just completed their newly piloted freedom from smoking program curriculum, tailored to black communities 'Freedom From Smoking®: My Glory. My Journey. Living a Tobacco-Free Life'. With the pilot complete, the team at HMA has been sharing these successes with local organizations and health systems in hopes to gain traction and interest to expand the program throughout the black community.
On August 12, the FDA granted approval to brensocatib, making it the first and only therapy specifically indicated for non-cystic fibrosis bronchiectasis (NCFB). This approval represents not just a regulatory milestone but a tangible step forward for patients and clinicians alike in managing a complex, under-treated respiratory disease.
As touchRESPIRATORY approaches 10 years of providing education for busy respiratory specialists, we are looking to the future—and it certainly looks bright!
In this Q&A, Professors David Price and David Halpin discuss their ATS 2025 abstract on improving COPD outcomes through a digital adherence support package. They explore the MAGNIFY trial's design, including how an EMR-driven algorithm identified high-risk patients and how a pharmacist-led intervention combined with a digital inhaler device significantly reduced treatment failure in a real-world primary care setting.
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career clinicians ready to think beyond the bedside and explore the business of medicine.
In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.
In this episode, Professor Irene Higginson, Director of Better Health and Care Futures at King’s College London, discusses the complex challenges of managing breathlessness. She explores non-pharmacological strategies, the value of multidisciplinary care, and how the Breathlessness Support Services at KCL are transforming patient support. Tune in for expert insights and a look at future directions in breathlessness research and care.
We are excited to welcome you to San Francisco for the ATS 2025 International Conference! Leaders, as well as emerging scientists and clinicians, who are at the forefront of medical breakthroughs and clinical innovation in pulmonary, critical care and sleep medicine will gather for networking and inspiring talks.
As 2024 comes to a close and as the new Patient Advisory Board & Advocacy Manager at EUFOREA, I have the privilege to reflect on the achievements and milestones of EUFOREA this year. With my background as a pharmacist and scientific ...
The International Primary Care Respiratory Group (IPCRG), is proud to host the 8th IPCRG Scientific Meeting in Brașov, Romania, on Friday 11 and Saturday 12 April 2025. This event, in partnership with the RespiRO team and the Transilvania University of Brașov promises to bring together researchers, innovators, and industry leaders to advance respiratory care in primary health settings.
COP29, currently underway in Baku, is bringing together global leaders to address the multifaceted issues of climate change, with healthcare firmly on the agenda. In a speech delivered by the WHO Director-General, Dr. Tedros Adhanom Ghebreyesus, he emphasized the critical link between climate change and human health, reinforcing that the climate crisis is, at its core, a health crisis. The escalating climate emergency is no longer a distant threat; it is already affecting human lives, particularly those of vulnerable groups like women and children.
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
